Julia spore biography

Julia Sporre was born on 23 December 1992.
Julia has led investments in Oxford Nanopore, Vaccitech, YuLife, AccuRx, CoMind, Vira, Hertility, and Spore Bio.
Read writing from Julia Hawkins on Medium.

•

Spore.Bio emerges from stealth and secures €8m pre-seed funding

Making consumer goods safer with a world-first bacteria detection device

Spore.Bio – a new deeptech startup behind the world’s first real-time pathogen detection device for factories – has raised €8m in pre-seed funding led by LocalGlobe to solve the critical health and safety challenges threatening the global FMCG market. The round also included participation from top-tier investors and angels with experience in industry, FMCG and AI, including EmergingTech Ventures, No Label Ventures, Famille C (Clarins Family Office), Better Angle, Mehdi Ghissassi (Google DeepMind), Roxane Varza (Station F) and more.* It will be used to accelerate the development and deployment of Spore.Bio’s AI-powered technology and grow its team.

A world first for pathogen detection

Spore.Bio was founded in 2023 by CEO Amine Raji (a food and beverage manufacturing expert who has worked at more than 50 factories around the world for companies such as Nestlé), CTO Maxime Mistretta, (PhD and Postdoctorate from Pasteur Institute in M

•

EU-Startups Podcast | Episode 96: Julia Hawkins, General Partner at LocalGlobe and Latitude

In this episode, we catch up with Julia Hawkins, General Partner at LocalGlobe and Latitude. Julia previously established Universal Music’s corporate venture arm and held roles at Goldman Sachs, Last.fm, and BBC Worldwide.

LocalGlobe is a London-based venture capital firm that has been seeding impactful founders since 1999, with investments in companies like Citymapper, Improbable, Lovefilm, Moo, Wise, and Zoopla. Julia has led investments in Oxford Nanopore, Vaccitech, YuLife, AccuRx, CoMind, Vira, Hertility, and Spore Bio. She is on a mission to support ambitious, thoughtful, and diverse founders in transforming healthcare—shifting from the scarcity of clinicians and appointments to ease of access through technology while enabling new and better treatments to reach patients.

Julia discusses overlooked trends in healthcare innovation, particularly drug shortages, and how her experiences navigating healthcare with her daughter have shaped her investment decisions. She shares insights int

•

Today, we have Julia Hawkins with us. Julia is a General Partner at Phoenix Court, a $1.5bn AUM EMEA multi-stage tech investor, backing the most ambitious founders on their journey from seed through to public markets and beyond over the last two decades. LocalGlobe is the pre-seed and seed fund investing out of Phoenix Court’s Fund 12 with an established portfolio of over 200 companies with notable investments including At-Bay, Motorway, Zego and Improbable. At Phoenix Court, Julia focuses on health and hard tech and led investments into AccuRx, Oxford Nanopore, Vaccitech, and more recently Spore Bio and Early Health.

Table of Contents | Scroll ⏬ for all guest show notes ✍️

Episode chapters.
Julia’s journey into venture.
Pivotal moment.
Take a stance.
Shout-out.
3 biggest learnings from 10 years in life.
Top tips for emerging VCs who are fundraising.
Most counterintuitive learning.

On the move? Listen to the eu.vc pod on Apple & Spotify 🎧

Scroll on ⏬For the chapters & core learnings 🧠

This episode i